Cerebral perfusion and its association with serum endothelin-1 in multiple sclerosis

References

• Uzuner N, Uzuner T. Cerebrovascular reactivity in multiple sclerosis. J Neurol Transl Neurosci. 2014;2(2):1051.
   Google Scholar
• De Keyser J, Steen C, Mostert J, et al. Hypoperfusion of the cerebral white matter in multiple sclerosis: possible mechanisms and pathophysiological significance. J Cereb Blood Flow Metab. 2008;28(10):1645–1651.
   Google Scholar
• Monti L, Morbidelli L, Rossi A. Impaired cerebral perfusion in multiple sclerosis: relevance of endothelial factors. Biomark Insights. 2018;13:1–10.
   Google Scholar
• Lapointe E, Li DKB, Traboulsee AL, et al. What have we learned from perfusion MRI in multiple sclerosis? AJNR Am J Neuroradiol. 2018;39(6):994–1000.
   Google Scholar
• D’haeseleer M, Hostenbach S, Peeters I, et al. Cerebral hypoperfusion: a new pathophysiologic concept in multiple sclerosis? J Cereb Blood Flow Metab. 2015;35(9):1406–1410.
   PubMed Web of Science ®Google Scholar
• Hostenbach S, Raeymaekers H, Van Schuerbeek P, et al. The Role of Cerebral Hypoperfusion in Multiple Sclerosis (ROCHIMS) trial in multiple sclerosis: insights from negative results. Front Neurol. 2020;11:674.
   PubMed Web of Science ®Google Scholar
• Polman C, Reingold S, Banwell B, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2011;69(2):292–302.
   PubMed Web of Science ®Google Scholar
• Ge Y, Law M, Johnson G, et al. Dynamic susceptibility contrast perfusion MR imaging of multiple sclerosis lesions: characterizing hemodynamic impairment and inflammatory activity. AJNR Am J Neuroradiol. 2005 Jun-Jul;26(6):1539–1547.
   PubMed Web of Science ®Google Scholar
• Varga AW, Johnson G, Babb JS, et al. White matter hemodynamic abnormalities precede sub-cortical gray matter changes in multiple sclerosis. J Neurol Sci. 2009 Jul 15;282(1–2):28–33.
   PubMed Web of Science ®Google Scholar
• Law M, Saindaine AM, Ge Y, et al. Microvascular abnormality in relapsing-remitting multiple sclerosis: perfusion MR imaging findings in normal-appearing white matter. Radiology. 2004;231(3):645–652.
   PubMed Web of Science ®Google Scholar
• Inglese M, Adhya S, Johnson G, et al. Perfusion magnetic resonance imaging correlates of neuropsychological impairment in multiple sclerosis. J Cereb Blood Flow Metab. 2008;28(1):164–171.
   PubMed Web of Science ®Google Scholar
• Adhya S, Johnson G, Herbert J, et al. Pattern of hemodynamic impairment in multiple sclerosis: dynamic susceptibility contrast perfusion MR imaging at 3.0 T. Neuroimage. 2006;33(4):1029–1035.
   PubMed Web of Science ®Google Scholar
• Debernard L, Melzer TR, Van Stockum S, et al. Reduced grey matter perfusion without volume loss in early relapsing-remitting multiple sclerosis. J Neurol Neurosurg Psychiatry. 2014; 85: 544–551.
   PubMed Web of Science ®Google Scholar
• Steen C, D’haeseleer M, Hoogduin JM, et al. Cerebral white matter blood flow and energy metabolism in multiple sclerosis. Mult Scler. 2013;19(10):1282–1289.
   PubMed Web of Science ®Google Scholar
• Narayana PA, Zhou Y, Hasan KM, et al. Hypoperfusion and T1-hypointense lesions in white matter in multiple sclerosis. Mult Scler. 2014;20(3):365–373.
   PubMed Web of Science ®Google Scholar
• Wuerfel J, Bellmann-Strobl J, Brunecker P, et al. Changes in cerebral perfusion precede plaque formation in multiple sclerosis: a longitudinal perfusion MRI study. Brain. 2004;127(Pt 1):111–119.
   PubMedGoogle Scholar
• Rashid W, Parkes LM, Ingle GT, et al. Abnormalities of cerebral perfusion in multiple sclerosis. J Neurol Neurosurg Psychiatry. 2004;75(9):1288–1293.
   PubMed Web of Science ®Google Scholar
• Bester M, Forkert ND, Stellmann JP, et al. Increased perfusion in normal appearing white matter in high inflammatory multiple sclerosis patients. PLoS One. 2015;10(3):e0119356.
   Google Scholar
• Papadaki EZ, Mastorodemos VC, Amanakis EZ, et al. White matter and deep gray matter hemodynamic changes in multiple sclerosis patients with clinically isolated syndrome. Magn Reson Med. 2012;68(6):1932–1942.
   PubMed Web of Science ®Google Scholar
• Doche E, Lecocq A, Maarouf A, et al. Hypoperfusion of the thalamus is associated with disability in relapsing remitting multiple sclerosis. J Neuroradiol. 2017;44(2):158–164.
   PubMed Web of Science ®Google Scholar
• Hyland M, Rudick RA. Challenges to clinical trials in multiple sclerosis: outcome measures in the era of disease-modifying drugs. Curr Opin Neurol. 2011;24(3):255–261.
   PubMedGoogle Scholar
• Haufschild T, Shaw SG, Kesselring J, et al. Increased endothelin-1 plasma levels in patients with multiple sclerosis. J Neuroophthalmol. 2001 Mar;21(1):37–38.
   Google Scholar
• Monti L, Morbidelli L, Bazzani L, et al. Influence of circulating endothelin-1 and asymmetric dimethylarginine on whole brain circulation time in multiple sclerosis. Biomark Insights. 2017;12:1177271917712514.
   Google Scholar
• Speciale L, Sarasella M, Ruzzante S, et al. Endothelin and nitric oxide levels in cerebrospinal fluid of patients with multiple sclerosis. J Neurovirol. 2000;6 Suppl 2(Suppl 2):S62–S66.
   Google Scholar
• Pache M, Kaiser HJ, Akhalbedashvili N, et al. Extraocular blood flow and endothelin-1 plasma levels in patients with multiple sclerosis. Eur Neurol. 2003;49:164–168.
   PubMed Web of Science ®Google Scholar
• D’Haeseleer M, Beelen R, Fierens Y, et al. Cerebral hypoperfusion in multiple sclerosis is reversible and mediated by endothelin-1. Proc Natl Acad Sci USA. 2013;110(14):5654–5658.
   PubMed Web of Science ®Google Scholar
• Jankowska-Lech I, Terelak-Borys B, Grabska-Liberek I, et al. Decreased endothelin-1 plasma levels in multiple sclerosis patients: a possible factor of vascular dysregulation? Med Sci Monit. 2015 Apr 13;21:1066–1071.
   PubMed Web of Science ®Google Scholar
• Pekny M, Pekna M, Messing A, et al. Astrocytes: a central element in neurological diseases. Acta Neuropathol. 2016 Mar;131(3):323–345.
   PubMed Web of Science ®Google Scholar
• Faraco G, Moraga A, Moore J, et al. Circulating endothelin-1 alters critical mechanisms regulating cerebral microcirculation. Hypertension. 2013 Oct;62(4):759–766.
   PubMed Web of Science ®Google Scholar